JENNIFER HAINES: Open Payments
NPI 1245672120 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 8 payments from 5 companies in 2025. Trend: 2023 $66 · 2024 $95 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: MOUNJARO, FEMLYV, INTRAROSA, MYFEMBREE, Ozempic, Rybelsus, CONTRAVE.
Industry payments across LA — which companies pay providers there.
